Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study

Leukemia. 2013 Jun;27(6):1430-3. doi: 10.1038/leu.2013.11. Epub 2013 Jan 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Interleukin-2 Receptor alpha Subunit / blood*
  • Male
  • Mastocytosis / blood*
  • Mastocytosis / pathology
  • Phenotype
  • Survival Analysis
  • Treatment Outcome

Substances

  • Interleukin-2 Receptor alpha Subunit